Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage.
Bioprosthetic heart valve (BHV) cusps have a complex architecture consisting of an anisotropic arrangement of collagen, glycosaminoglycans (GAGs) and elastin. Glutaraldehyde (GLUT) is used as a fixative for all clinical BHV implants; however, it only stabilizes the collagen component of the tissue, and other components such as GAGs and elastin are lost from the tissue during processing, storage or after implantation. We have shown previously that the effectiveness of the chemical crosslinking can be increased by incorporating neomycin trisulfate, a hyaluronidase inhibitor, to prevent the enzyme-mediated GAG degradation. In the present study, we optimized carbodiimide-based GAG-targeted chemistry to incorporate neomycin into BHV cusps prior to conventional GLUT crosslinking. This crosslinking leads to enhanced preservation of GAGs during in vitro cyclic fatigue and storage. The neomycin group showed greater GAG retention after both 10 and 50 million accelerated fatigue cycles and after 1 year of storage in GLUT solution. Thus, additional binding of neomycin to the cusps prior to standard GLUT crosslinking could enhance tissue stability and thus heart valve durability.
Raghavan
Devanathan
D
Cardiovascular Implant Research Laboratory (CIRL), Department of Bioengineering, Clemson University, 501 Rhodes Hall, Clemson, SC 29634, USA.
Starcher
Barry C
BC
Vyavahare
Naren R
NR
D003094:Collagen / Q000378:metabolism; D003432:Cross-Linking Reagents; D004549:Elastin; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism*; D006350:Heart Valve Prosthesis; D006595:Hexosamines; D006821:Hyaluronoglucosaminidase / Q000037:antagonists & inhibitors / Q000378:metabolism; D009355:Neomycin / Q000378:metabolism* / Q000494:pharmacology; D013314:Stress, Mechanical; D013997:Time Factors
D003432:Cross-Linking Reagents; D006595:Hexosamines; C002980:streptamine; D003094:Collagen; D004549:Elastin; D006821:Hyaluronoglucosaminidase; D009355:Neomycin